Cardiovascular follow-up after a hypertensive disorder of pregnancy
Guideline | Year | Follow-up CVD risk |
Guidelines with no recommendations regarding cardiovascular follow-up | ||
WHO* | 2011 | None |
ISSHP | - | None |
Guidelines with no specific timeline recommendations regarding cardiovascular follow-up | ||
ACOG | 2013 and 2018 | Women with preterm delivery (<37 weeks) or recurrent pre-eclampsia: annual blood pressure, lipids, fasting glucose and BMI. No recommendation on starting time and which healthcare provider. |
RCOG44 | 2006 | Inform about increased CVD risk in the future. |
SOGC45 | 2014 | Assessment of traditional cardiovascular risk markers may be beneficial. Encourage a healthy diet and lifestyle, especially, for overweight women. |
Guidelines with timeline recommendations regarding cardiovascular follow-up | ||
NICE† | 2017 | Discuss future CVD risk 6–8 weeks after pregnancy with healthcare provider. |
ASA43 | 2014 | Consider to evaluate and treat all women with a history of pre-eclampsia for cardiovascular risk factors such as hypertension, obesity, smoking and dyslipidemia, starting 6 months to 1 year post partum. |
ESC/ESH42 46 | 2018 | Annual check of blood pressure and metabolic factors by primary care physician. |
SOMANZ47 | 2014 | Cardiovascular risk assessment every 5 years. |
AHA39 49 | 2011/2018 | Postpartum referral by the obstetrician to a primary care physician or cardiologist to monitor and control cardiovascular risk factors. Consider statin therapy in women with 10-year ASCVD risk of 5%–7.5%. |
NVOG50 | 2014 | Cardiovascular risk assessment at the age of 50 years. |
*WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia, 2011.
†Hypertension in pregnancy, 2013 (updated 2017).
ACOG, American College of Obstetricians and Gynecologists; AHA, American Heart Association; ASA, American Stroke Association; ASCVD, atherosclerotic cardiovascular disease; ESC, European Society of Cardiology; ESH, European Society of Hypertension; ISSHP, International Society for the study of Hypertension in Pregnancy; NICE, National Institute for Health and Care Excellence; NVOG, Nederlandse Vereniging voor Obstetrie en Gynaecologie; RCOG, Royal College of Obstetricians and Gynaecologists; SOGC, Society of Obstetricians and Gynecologists of Canada; SOMANZ, Society of Obstetric Medicine Australia and New Zealand.